Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.
iSpot.tv, Inc. is a company specializing in real-time analytics for television advertising, providing insights into the effectiveness of ad campaigns across various broadcast and cable networks, as well as smart TVs. Founded in 2012 and headquartered in Bellevue, Washington, iSpot.tv offers a platform that allows advertisers to track ad creatives, airings, spending, and viewer impressions with a level of precision akin to digital metrics. The platform measures consumer engagement, assesses the impact of TV and streaming ads on sales, and provides actionable insights that enable advertisers to refine their media strategies and enhance creative effectiveness. iSpot.tv serves a diverse clientele, including television brands, networks, and studios, helping them to gauge the business impact of their advertising efforts in real-time.
Moonshoot
Venture Round in 2012
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.
Pivotal Systems
Venture Round in 2012
Pivotal Systems Corporation specializes in designing, developing, manufacturing, and selling gas flow controllers for the semiconductor industry, primarily serving markets in Asia and North America. Founded in 2003 and headquartered in Fremont, California, the company offers a technology platform that includes gas flow controllers, monitors, and sensors, which facilitate real-time monitoring and control of critical parameters in wafer processing. By leveraging advanced machine learning, Pivotal Systems enhances preventive diagnostics, significantly improving productivity and capital efficiency in semiconductor fabrication. Its customer base comprises integrated device manufacturers, foundries, and original equipment manufacturers, with a notable revenue concentration in the Asia region.
Global Education Learning
Venture Round in 2012
Global Education Learning (GEL) is dedicated to providing top-tier educational products and services to young Chinese children, focusing on essential subjects such as English, Chinese, math, and science while also fostering emotional intelligence, creativity, and strong values. GEL operates through its subsidiary, Yaolan, which is a trusted platform catering to parents of children aged 0-6, boasting a significant national presence. The company's strategy is built on a robust multi-pronged distribution network that spans first, second, and third tier cities across China, distinguishing GEL in the competitive landscape. The initial phase of its strategy emphasizes establishing this distribution engine with Yaolan as the online foundation, complemented by offline learning centers and physical stores. In subsequent phases, GEL aims to invest in world-class educational content and technology sourced both domestically and internationally. With a strong management team and a commitment to innovative educational solutions, GEL positions itself as a key partner for early education products and services entering the Chinese market.
Noble Biomaterials
Series B in 2012
Noble Biomaterials, Inc. is a leading provider of antimicrobial and conductivity solutions, primarily focusing on soft surface applications. Founded in 1997 and based in Scranton, Pennsylvania, the company specializes in advanced materials that utilize silver-based technologies to enhance product performance. Its offerings include X-STATIC, an antimicrobial technology that protects against bacteria, fungi, and odors, and XT2, which provides long-lasting antimicrobial protection. Noble Biomaterials also develops CIRCUITEX, a solution for biometric monitoring and conductive protection, catering to various industries such as healthcare, aerospace, electronics, and military markets. The company maintains a global presence with additional offices in Europe, Asia, and South America and has established strategic partnerships with organizations like ANTA Sports Products Limited and Pure Air Filtration, LLC. Noble Biomaterials is recognized for its commitment to innovation and its role as a US EPA-registered antimicrobial manufacturer, supplying critical medical components to the US military and other sectors.
Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.
BostInno
Seed Round in 2011
BostInno is a Boston-based online news portal that delivers news related to business, technology, education, and sports. It is operated by [Streetwise Media](http://www.crunchbase.com/organization/streetwise-media), a digital media and events company. Its editorial staff consists of fast, edgy, and opinionated members, and it is an open community publishing platform. BostInno was founded in 2001 and is based in Boston, M.A.
SkyCross is a global company specializing in the design and manufacture of advanced antenna and radiofrequency technology systems. The company serves various market segments, including handsets, data cards, USB dongles, laptops, access points, and mobile personal entertainment devices. SkyCross's technology focuses on producing integrated modules and antennas based on patented technologies such as beam-forming, pattern diversity, and closed-loop tuning. These innovations aim to enhance the development of mobile and connectivity applications, improving communication across all wireless devices.
AirWalk Communications
Series B in 2011
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company's innovative approach integrates decentralized controller functionality with base station transceivers into a single compact device, resulting in reduced equipment complexity and latency. This design enhances reliability, simplifies installation, and lowers costs while minimizing the system footprint for service providers. AirWalk's product offerings include the EdgePoint Femtocell, designed for homes and small offices, the EdgePoint PRO for larger office and campus environments, the PilotStation for managing overhead channels in CDMA networks, and the Base Station Manager, which is an open standards-based solution for efficient operation and administration of its software systems.
Celator Pharmaceuticals
Series D in 2010
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company designs and evaluates optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Notable products in its pipeline include VYXEOS, a nano-scale liposomal formulation of irinotecan and floxuridine, and CPX-351, a liposomal formulation of cytarabine and daunorubicin, both in Phase III clinical trials for acute myeloid leukemia. Additionally, CPX-1, a liposomal formulation of irinotecan and floxuridine, has completed Phase II studies for colorectal cancer. Celator also has a preclinical candidate, CPX-8, which is a hydrophobic docetaxel prodrug nanoparticle formulation. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.
Velsys
Venture Round in 2010
Velsys Limited is a global independent financial technology services provider specializing in foreign exchange (FX) trading solutions for banks, brokers, and financial institutions. Founded in 1996 and headquartered in Adelaide, Australia, with an additional office in London, Velsys delivers a core set of FX software applications designed for various deployment options, including a fully hosted service. Its offerings include V-Banking, a web-based e-trading platform that facilitates the development, management, and electronic distribution of financial products, enhancing pricing, liquidity, and connectivity for clients. Velsys is committed to supporting both large and smaller financial institutions worldwide, catering particularly to the needs of mid- and smaller-sized regional banks.
Moonshoot
Venture Round in 2010
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.
Translarity
Series B in 2009
Translarity, headquartered in Silicon Valley, specializes in innovative semiconductor wafer testing solutions, focusing on advanced probe card markets. The company pioneers full-wafer testing with low cost, high performance, and short cycle times. In 2017, Translarity acquired BucklingBeam to expand its offerings, now providing a comprehensive suite of probe card solutions including full probe cards and vertical probe head solutions. Leveraging its proprietary Space Translator™ technology, Translarity addresses the rapid evolution in probe technologies. Led by an experienced management team and supported by strong financial investors, Translarity has recruited top industry talent to develop Wafer Translator™ technology, resulting in a robust IP portfolio with over 45 issued patents and more than 50 filed.
Finite Carbon
Series A in 2009
Finite Carbon Corporation is a company based in Wayne, Pennsylvania, that specializes in forest carbon development and commercialization services across the United States. Established in 2009, it offers a comprehensive solution for forest landowners to access carbon markets, facilitating the measurement, registration, monitoring, and monetization of carbon credits. The company provides essential resources such as carbon inventories, pre-assessment modeling, protocol selection, project design, and verification management. Finite Carbon also assumes all risks and expenses related to project issuance and manages the entire development process internally. By collaborating closely with landowners, public agencies, land trusts, and consulting foresters, Finite Carbon ensures that carbon projects align with clients' forest management goals and timber operations. As of December 2020, Finite Carbon operates as a subsidiary of BP p.l.c.
Celator Pharmaceuticals
Series C in 2008
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company designs and evaluates optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Notable products in its pipeline include VYXEOS, a nano-scale liposomal formulation of irinotecan and floxuridine, and CPX-351, a liposomal formulation of cytarabine and daunorubicin, both in Phase III clinical trials for acute myeloid leukemia. Additionally, CPX-1, a liposomal formulation of irinotecan and floxuridine, has completed Phase II studies for colorectal cancer. Celator also has a preclinical candidate, CPX-8, which is a hydrophobic docetaxel prodrug nanoparticle formulation. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.
ScaleMP, Inc. specializes in virtualization solutions for high-end computing, enabling organizations to create virtual large-memory systems from standard x86 servers. Founded in 2003 and headquartered in Fort Lee, New Jersey, the company offers a range of products, including the vSMP Foundation, which aggregates multiple servers into a single virtual system, and the vSMP Foundation Advanced Platform, designed for on-demand symmetric multiprocessing. ScaleMP's technology supports various applications, such as analytics, big data, and computational simulations, while providing significant performance improvements and reduced total cost of ownership. Their innovative architecture simplifies cluster management and maintains stable performance across industries, including life sciences, manufacturing, education, and financial services. The company distributes its products through channel partners and regional sellers both in the United States and internationally.
Kleer combines an advanced, cloud-based platform with dedicated and personalized support to ensure your practice has everything you need to easily and quickly design, implement, and professionally manage a successful membership plan. Kleer has implemented membership plans for 7,000+ dentists and has a team dedicated to your success.
AirWalk Communications
Series B in 2008
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company's innovative approach integrates decentralized controller functionality with base station transceivers into a single compact device, resulting in reduced equipment complexity and latency. This design enhances reliability, simplifies installation, and lowers costs while minimizing the system footprint for service providers. AirWalk's product offerings include the EdgePoint Femtocell, designed for homes and small offices, the EdgePoint PRO for larger office and campus environments, the PilotStation for managing overhead channels in CDMA networks, and the Base Station Manager, which is an open standards-based solution for efficient operation and administration of its software systems.
Sopherion Therapeutics
Venture Round in 2008
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.
NorthStar Systems International
Venture Round in 2007
NorthStar Systems International, Inc. provides wealth management software solutions to financial services institutions primarily in the United States. Its solutions include NorthStar Client Acquisition Solution that allows asset managers and wealth management firms to provide their advisors the client profiling and communication tools; NorthStar Client Reporting Solution, which enables wealth managers to offer reports and reviews for clients; NorthStar Compliance Solution that offers compliance systems' functionalities; and NorthStar Product Catalog Solution, which allows wealth managers to build customized portfolios. The company also offers client hierarchy, enterprise product hub, planning and portfolio construction, data, and platform services; and professional and technical support services. Its solutions allow users to automate and streamline their wealth management workflows. The company serves financial advisors, wealth managers, banks, trusts, broker-dealers, multi-family offices, and service providers. It delivers its solutions on-premise or on-demand. The company was founded in 2001 and is based in San Francisco, California.
Optichron
Venture Round in 2007
Optichron, Inc. is a prominent company specializing in nonlinear signal processing technology, established in January 2003. The company designs and manufactures integrated circuits that address the challenges of nonlinear distortion, a critical barrier in signal processing across various industries. Recognized by industry experts as a major impediment to achieving optimal performance in communications and data conversion, nonlinear distortion has been historically managed by inefficient methods. Optichron has developed a proprietary mathematical approach that underpins its robust integrated circuit architecture, leading to innovative linearization products. These products efficiently eliminate all forms of nonlinear distortion, significantly enhancing system design parameters while reducing component count, overall costs, and power consumption. Optichron's technology is utilized in diverse applications, including wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation, providing substantial improvements in system-level cost and performance.
Celator Pharmaceuticals
Series C in 2007
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company designs and evaluates optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Notable products in its pipeline include VYXEOS, a nano-scale liposomal formulation of irinotecan and floxuridine, and CPX-351, a liposomal formulation of cytarabine and daunorubicin, both in Phase III clinical trials for acute myeloid leukemia. Additionally, CPX-1, a liposomal formulation of irinotecan and floxuridine, has completed Phase II studies for colorectal cancer. Celator also has a preclinical candidate, CPX-8, which is a hydrophobic docetaxel prodrug nanoparticle formulation. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.
QuatRx Pharmaceuticals
Series E in 2007
QuatRx Pharmaceuticals is a biopharmaceutical company based in Ann Arbor, Michigan, founded in 2000. The company specializes in the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Its key product, Osphena, addresses vaginal atrophy, a condition commonly associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related health issues in men, reflecting its commitment to advancing healthcare solutions in these therapeutic areas.
NetEffect Sytems
Series C in 2007
NetEffect has offered dependable cybersecurity and IT services to companies in Las Vegas.
Ciclon Semiconductor Device
Series B in 2007
Ciclon Semiconductor Device Corporation is a prominent designer and manufacturer of high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions tailored for advanced information technology applications. Established in 2004 and headquartered in Bethlehem, Pennsylvania, the company specializes in providing RF and power semiconductor products that include both ceramic and plastic packaged RoHS-compliant discrete options. These products serve a diverse range of RF power applications, including communications, military, avionic, broadcast, and WiMax. Since February 2009, Ciclon operates as a subsidiary of Texas Instruments Inc.
Atrenta
Venture Round in 2006
Atrenta is a provider of innovative solutions for the semiconductor and consumer electronics industries, specializing in design efficiency through its SpyGlass Predictive Analysis software platform. This platform offers early design insights into the performance, power, and area requirements of complex system on chips (SoCs), which are essential for modern consumer electronics. By enabling design engineers to identify structural, coding, and consistency issues in register transfer language (RTL), Atrenta's technology allows for enhanced testability during RTL creation. The company's patented solutions are utilized by over two hundred companies and thousands of design engineers globally, helping to mitigate risks and reduce costs before the deployment of traditional electronic design automation (EDA) tools. SpyGlass serves as an interactive guidance system, optimizing the implementation process for complex SoCs and ensuring greater efficiency and confidence in design outcomes.
AirWalk Communications
Series B in 2006
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company's innovative approach integrates decentralized controller functionality with base station transceivers into a single compact device, resulting in reduced equipment complexity and latency. This design enhances reliability, simplifies installation, and lowers costs while minimizing the system footprint for service providers. AirWalk's product offerings include the EdgePoint Femtocell, designed for homes and small offices, the EdgePoint PRO for larger office and campus environments, the PilotStation for managing overhead channels in CDMA networks, and the Base Station Manager, which is an open standards-based solution for efficient operation and administration of its software systems.
VeriWave is a company that specializes in testing systems for WiFi and Ethernet networks, focusing on ensuring optimal performance for mobile networks, devices, and applications. It provides a range of tools designed to assess local area networks (LAN) and wireless LANs, enabling manufacturers, service providers, and users to measure, analyze, and enhance critical aspects of mobile performance, including speed, quality, interoperability, and compliance. In addition to testing solutions, VeriWave offers products such as WiFi access points, wireless LAN controllers, residential routers, gateways, and Ethernet switches, catering to the needs of equipment manufacturers and enhancing the overall functionality of mobile networks.
JAM Technologies
Series B in 2006
JAM Technologies operates as a mixed signal semiconductor company. It designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. JamTech offers True Fidelity sub-ranging pulse width modulation digital amplifiers. It sells its ICs through direct sales force and distributors. The company was founded in 1999 and is headquartered in Austin, Texas, with an additional office in Singapore.
ClariFI
Venture Round in 2006
ClariFI, Inc. provides software and services focusing on quantitative investment management and research. It offers ModelStation, a solution with data management, factor backtesting, model construction, strategy simulation, portfolio optimization, risk and performance attribution, production scheduling, and enterprise adoption modules. The company's services include data integration and management, workflow creation, statistical/computational algorithms, risk model development, forecast model development, and strategy script development. It also provides integration services to in-house data warehouses or custom feeds. The company was founded in 1999 and is headquartered in New York, New York with additional offices in Boston, Massachusetts; El Segundo, California; and London, United Kingdom. As of May 15, 2007, ClariFI, Inc. operates as a subsidiary of Capital IQ, Inc.
SkyCross is a global company specializing in the design and manufacture of advanced antenna and radiofrequency technology systems. The company serves various market segments, including handsets, data cards, USB dongles, laptops, access points, and mobile personal entertainment devices. SkyCross's technology focuses on producing integrated modules and antennas based on patented technologies such as beam-forming, pattern diversity, and closed-loop tuning. These innovations aim to enhance the development of mobile and connectivity applications, improving communication across all wireless devices.
Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.
Translarity
Series A in 2005
Translarity, headquartered in Silicon Valley, specializes in innovative semiconductor wafer testing solutions, focusing on advanced probe card markets. The company pioneers full-wafer testing with low cost, high performance, and short cycle times. In 2017, Translarity acquired BucklingBeam to expand its offerings, now providing a comprehensive suite of probe card solutions including full probe cards and vertical probe head solutions. Leveraging its proprietary Space Translator™ technology, Translarity addresses the rapid evolution in probe technologies. Led by an experienced management team and supported by strong financial investors, Translarity has recruited top industry talent to develop Wafer Translator™ technology, resulting in a robust IP portfolio with over 45 issued patents and more than 50 filed.
QuatRx Pharmaceuticals
Series D in 2005
QuatRx Pharmaceuticals is a biopharmaceutical company based in Ann Arbor, Michigan, founded in 2000. The company specializes in the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Its key product, Osphena, addresses vaginal atrophy, a condition commonly associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related health issues in men, reflecting its commitment to advancing healthcare solutions in these therapeutic areas.
Ciclon Semiconductor Device
Series A in 2005
Ciclon Semiconductor Device Corporation is a prominent designer and manufacturer of high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions tailored for advanced information technology applications. Established in 2004 and headquartered in Bethlehem, Pennsylvania, the company specializes in providing RF and power semiconductor products that include both ceramic and plastic packaged RoHS-compliant discrete options. These products serve a diverse range of RF power applications, including communications, military, avionic, broadcast, and WiMax. Since February 2009, Ciclon operates as a subsidiary of Texas Instruments Inc.
Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the development of drug candidates aimed at treating pain and inflammation. The company specializes in ion-channel modulation, using its expertise to discover therapeutics that may effectively block ion channels in neuronal cells responsible for pain signal transmission. Zalicus has invested significantly in its drug discovery technology, as well as the research and development of its product candidates, which includes conducting preclinical and clinical trials. The company has also sought intellectual property protection for its innovative technologies. Its notable achievement includes the approval of Exalgo, an extended-release formulation of hydromorphone for managing moderate to severe pain in opioid-tolerant patients, granted by the United States Food and Drug Administration in 2010. Additionally, Zalicus merged with Neuromed Pharmaceuticals in 2009, further expanding its capabilities in pain management therapies.
Intellon Corporation
Series B in 2005
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.
Apogee Photonics
Venture Round in 2005
Apogee Photonics, Inc. is a company specializing in the design, development, and production of advanced optoelectronic solutions for optical transmission systems. Founded in 2000 and headquartered in Allentown, Pennsylvania, with an additional office in New Jersey, Apogee Photonics offers integrated indium phosphide products that enhance the distance-extinction-power product compared to other optical semiconductor technologies. Their product range includes cooled, semi-cooled, and uncooled solutions for 10Gb/s and 40Gb/s transmission, catering to tier 1 system original equipment manufacturers (OEMs) and module vendors. Key offerings encompass thermistor-based temperature monitoring, modulator-based power monitoring products, electroabsorption-modulated lasers, and laser integrated modulators. The company extends its market presence through sales locations in the United States, Canada, Europe, Israel, and Asia.
VeriWave is a company that specializes in testing systems for WiFi and Ethernet networks, focusing on ensuring optimal performance for mobile networks, devices, and applications. It provides a range of tools designed to assess local area networks (LAN) and wireless LANs, enabling manufacturers, service providers, and users to measure, analyze, and enhance critical aspects of mobile performance, including speed, quality, interoperability, and compliance. In addition to testing solutions, VeriWave offers products such as WiFi access points, wireless LAN controllers, residential routers, gateways, and Ethernet switches, catering to the needs of equipment manufacturers and enhancing the overall functionality of mobile networks.
Celator Pharmaceuticals
Series B in 2005
Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company designs and evaluates optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Notable products in its pipeline include VYXEOS, a nano-scale liposomal formulation of irinotecan and floxuridine, and CPX-351, a liposomal formulation of cytarabine and daunorubicin, both in Phase III clinical trials for acute myeloid leukemia. Additionally, CPX-1, a liposomal formulation of irinotecan and floxuridine, has completed Phase II studies for colorectal cancer. Celator also has a preclinical candidate, CPX-8, which is a hydrophobic docetaxel prodrug nanoparticle formulation. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.
Ventaira Pharmaceuticals
Series C in 2005
Ventaira Pharmaceuticals is a specialty pharmaceutical company dedicated to developing innovative inhalation products. Utilizing its proprietary electrohydrodynamic (EHD) aerosolization technology, Ventaira focuses on creating novel inhaled drugs, such as fentanyl for managing breakthrough pain and salmeterol for treating asthma.
Optichron
Series B in 2005
Optichron, Inc. is a prominent company specializing in nonlinear signal processing technology, established in January 2003. The company designs and manufactures integrated circuits that address the challenges of nonlinear distortion, a critical barrier in signal processing across various industries. Recognized by industry experts as a major impediment to achieving optimal performance in communications and data conversion, nonlinear distortion has been historically managed by inefficient methods. Optichron has developed a proprietary mathematical approach that underpins its robust integrated circuit architecture, leading to innovative linearization products. These products efficiently eliminate all forms of nonlinear distortion, significantly enhancing system design parameters while reducing component count, overall costs, and power consumption. Optichron's technology is utilized in diverse applications, including wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation, providing substantial improvements in system-level cost and performance.
T-Networks
Series C in 2005
Electronic Components, Modulators available from T-Networks Inc. based in Allentown, PA.
Blaze Public Relations
Venture Round in 2005
The Blaze Company provides marketing communications services to travel, retail, entertainment, magazines, institutes, and financial services industries. The company offers press conference, media placement analysis, direct mail, event marketing, public relations, online research, and strategic corporate counsel. Its clientele includes Seagrams, Denis Austin, Cruise & Resort Magazine, Hollywood Marketing Corporation, Cafй Med, Tomy America Inc., and Glad Bags. The company is based in Venice, California. As of 05/12/2004, The Blaze Company is a subsidiary of Davies.
QuatRx Pharmaceuticals
Series D in 2004
QuatRx Pharmaceuticals is a biopharmaceutical company based in Ann Arbor, Michigan, founded in 2000. The company specializes in the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Its key product, Osphena, addresses vaginal atrophy, a condition commonly associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related health issues in men, reflecting its commitment to advancing healthcare solutions in these therapeutic areas.
Sopherion Therapeutics
Series B in 2004
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.
AirWalk Communications
Series A in 2004
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company's innovative approach integrates decentralized controller functionality with base station transceivers into a single compact device, resulting in reduced equipment complexity and latency. This design enhances reliability, simplifies installation, and lowers costs while minimizing the system footprint for service providers. AirWalk's product offerings include the EdgePoint Femtocell, designed for homes and small offices, the EdgePoint PRO for larger office and campus environments, the PilotStation for managing overhead channels in CDMA networks, and the Base Station Manager, which is an open standards-based solution for efficient operation and administration of its software systems.
Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.
Atrenta is a provider of innovative solutions for the semiconductor and consumer electronics industries, specializing in design efficiency through its SpyGlass Predictive Analysis software platform. This platform offers early design insights into the performance, power, and area requirements of complex system on chips (SoCs), which are essential for modern consumer electronics. By enabling design engineers to identify structural, coding, and consistency issues in register transfer language (RTL), Atrenta's technology allows for enhanced testability during RTL creation. The company's patented solutions are utilized by over two hundred companies and thousands of design engineers globally, helping to mitigate risks and reduce costs before the deployment of traditional electronic design automation (EDA) tools. SpyGlass serves as an interactive guidance system, optimizing the implementation process for complex SoCs and ensuring greater efficiency and confidence in design outcomes.
Ikanos Communications designs, develops, markets, and sells semiconductors and integrated firmware products for connected home networks worldwide. Its offerings include DSL processors, gateway processors, and multi-mode communications processors supporting various network topologies like Ethernet, PON, DSL, and LTE. Serving network equipment manufacturers, original design manufacturers, and other clients through direct sales and distributors, Ikanos operates as a subsidiary of Qualcomm Atheros since 2015, headquartered in Fremont, California.
Intellon Corporation
Venture Round in 2004
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.
CombinatoRx
Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.
CorrectNet
Series B in 2004
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for major investment management firms. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. Its services are facilitated through the InfiPOINT platform, which enhances client reporting capabilities, and the Advisor WebTools portal designed for wealth advisors and registered investment advisors. CorrectNet is known for its ability to meet stringent transparency and reporting standards, serving a diverse clientele that includes hedge funds, funds of funds, fund administrators, and prime brokers. The company's expertise ensures that investors, portfolio managers, operations teams, and executives receive comprehensive and timely reporting through advanced web portals.
Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the development of drug candidates aimed at treating pain and inflammation. The company specializes in ion-channel modulation, using its expertise to discover therapeutics that may effectively block ion channels in neuronal cells responsible for pain signal transmission. Zalicus has invested significantly in its drug discovery technology, as well as the research and development of its product candidates, which includes conducting preclinical and clinical trials. The company has also sought intellectual property protection for its innovative technologies. Its notable achievement includes the approval of Exalgo, an extended-release formulation of hydromorphone for managing moderate to severe pain in opioid-tolerant patients, granted by the United States Food and Drug Administration in 2010. Additionally, Zalicus merged with Neuromed Pharmaceuticals in 2009, further expanding its capabilities in pain management therapies.
Blaze is the safest, easiest, and most fun way to play online games.
Netrake Corporation specializes in providing voice and multimedia solutions for Internet protocol (IP) networks, serving a range of operators including wireline, wireless, cable, and fixed/mobile entities. Founded in 2000 and based in Plano, Texas, the company develops session border controllers that facilitate connectivity, enforce policies, and ensure security for Voice over IP (VoIP) and video sessions across IP networks. Additionally, Netrake offers security gateways that enable secure real-time communications over Wi-Fi, broadband, and wireless networks, supporting fixed mobile convergence. Its product suite is designed to enhance carrier-to-carrier peering, residential and Internet service provider capabilities, as well as business VoIP access services. Netrake operates as a subsidiary of AudioCodes, Inc. since 2006.
VeriWave is a company that specializes in testing systems for WiFi and Ethernet networks, focusing on ensuring optimal performance for mobile networks, devices, and applications. It provides a range of tools designed to assess local area networks (LAN) and wireless LANs, enabling manufacturers, service providers, and users to measure, analyze, and enhance critical aspects of mobile performance, including speed, quality, interoperability, and compliance. In addition to testing solutions, VeriWave offers products such as WiFi access points, wireless LAN controllers, residential routers, gateways, and Ethernet switches, catering to the needs of equipment manufacturers and enhancing the overall functionality of mobile networks.
AirWalk Communications
Venture Round in 2003
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company's innovative approach integrates decentralized controller functionality with base station transceivers into a single compact device, resulting in reduced equipment complexity and latency. This design enhances reliability, simplifies installation, and lowers costs while minimizing the system footprint for service providers. AirWalk's product offerings include the EdgePoint Femtocell, designed for homes and small offices, the EdgePoint PRO for larger office and campus environments, the PilotStation for managing overhead channels in CDMA networks, and the Base Station Manager, which is an open standards-based solution for efficient operation and administration of its software systems.
QuatRx Pharmaceuticals
Series C in 2003
QuatRx Pharmaceuticals is a biopharmaceutical company based in Ann Arbor, Michigan, founded in 2000. The company specializes in the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Its key product, Osphena, addresses vaginal atrophy, a condition commonly associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related health issues in men, reflecting its commitment to advancing healthcare solutions in these therapeutic areas.
AirWalk Communications
Series A in 2003
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company's innovative approach integrates decentralized controller functionality with base station transceivers into a single compact device, resulting in reduced equipment complexity and latency. This design enhances reliability, simplifies installation, and lowers costs while minimizing the system footprint for service providers. AirWalk's product offerings include the EdgePoint Femtocell, designed for homes and small offices, the EdgePoint PRO for larger office and campus environments, the PilotStation for managing overhead channels in CDMA networks, and the Base Station Manager, which is an open standards-based solution for efficient operation and administration of its software systems.
Atrenta is a provider of innovative solutions for the semiconductor and consumer electronics industries, specializing in design efficiency through its SpyGlass Predictive Analysis software platform. This platform offers early design insights into the performance, power, and area requirements of complex system on chips (SoCs), which are essential for modern consumer electronics. By enabling design engineers to identify structural, coding, and consistency issues in register transfer language (RTL), Atrenta's technology allows for enhanced testability during RTL creation. The company's patented solutions are utilized by over two hundred companies and thousands of design engineers globally, helping to mitigate risks and reduce costs before the deployment of traditional electronic design automation (EDA) tools. SpyGlass serves as an interactive guidance system, optimizing the implementation process for complex SoCs and ensuring greater efficiency and confidence in design outcomes.
Immunicon
Series F in 2003
Immunicon is a developer and manufacturer of proprietary cell-based diagnostic and research products, primarily focusing on cancer detection and monitoring. The company specializes in ultra-high sensitivity cancer detection test kits and next-generation cell analysis instruments. Their technologies, branded as CellTracks, are designed to identify, count, and characterize tumor cells in blood samples, providing physicians with clinically meaningful information earlier than traditional diagnostic methods. A notable collaboration with Veridex, a Johnson & Johnson company, has led to the submission of a pre-market notification for the CellSearch Epithelial Cell Kit, aimed at enhancing the management of metastatic breast cancer. Immunicon believes its technologies not only hold promise for cancer diagnostics but may also be applicable in other medical fields, including cardiovascular and infectious diseases, thereby contributing to the advancement of medical research and treatment.
Ikanos Communications designs, develops, markets, and sells semiconductors and integrated firmware products for connected home networks worldwide. Its offerings include DSL processors, gateway processors, and multi-mode communications processors supporting various network topologies like Ethernet, PON, DSL, and LTE. Serving network equipment manufacturers, original design manufacturers, and other clients through direct sales and distributors, Ikanos operates as a subsidiary of Qualcomm Atheros since 2015, headquartered in Fremont, California.
eRealty.com
Series E in 2003
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.
QuatRx Pharmaceuticals
Series C in 2003
QuatRx Pharmaceuticals is a biopharmaceutical company based in Ann Arbor, Michigan, founded in 2000. The company specializes in the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Its key product, Osphena, addresses vaginal atrophy, a condition commonly associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related health issues in men, reflecting its commitment to advancing healthcare solutions in these therapeutic areas.
BayPackets
Series C in 2003
BayPackets' software enables wireless, wireline and cable operators to rapidly bundle and deliver enhanced voice and data services tailored to the needs of their business and consumer customers. Local, long-distance and broadband service providers rely on BayPackets' solutions to profitably expand their market share by efficiently operating new and existing network infrastructure via a single point.
Sopherion Therapeutics
Series A in 2003
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.
Ventaira Pharmaceuticals
Series B in 2003
Ventaira Pharmaceuticals is a specialty pharmaceutical company dedicated to developing innovative inhalation products. Utilizing its proprietary electrohydrodynamic (EHD) aerosolization technology, Ventaira focuses on creating novel inhaled drugs, such as fentanyl for managing breakthrough pain and salmeterol for treating asthma.
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.
eRealty.com
Series D in 2002
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.
Netrake Corporation specializes in providing voice and multimedia solutions for Internet protocol (IP) networks, serving a range of operators including wireline, wireless, cable, and fixed/mobile entities. Founded in 2000 and based in Plano, Texas, the company develops session border controllers that facilitate connectivity, enforce policies, and ensure security for Voice over IP (VoIP) and video sessions across IP networks. Additionally, Netrake offers security gateways that enable secure real-time communications over Wi-Fi, broadband, and wireless networks, supporting fixed mobile convergence. Its product suite is designed to enhance carrier-to-carrier peering, residential and Internet service provider capabilities, as well as business VoIP access services. Netrake operates as a subsidiary of AudioCodes, Inc. since 2006.
Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the development of drug candidates aimed at treating pain and inflammation. The company specializes in ion-channel modulation, using its expertise to discover therapeutics that may effectively block ion channels in neuronal cells responsible for pain signal transmission. Zalicus has invested significantly in its drug discovery technology, as well as the research and development of its product candidates, which includes conducting preclinical and clinical trials. The company has also sought intellectual property protection for its innovative technologies. Its notable achievement includes the approval of Exalgo, an extended-release formulation of hydromorphone for managing moderate to severe pain in opioid-tolerant patients, granted by the United States Food and Drug Administration in 2010. Additionally, Zalicus merged with Neuromed Pharmaceuticals in 2009, further expanding its capabilities in pain management therapies.
Participate Systems
Series D in 2002
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.
Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.
BroadCloud Communications
Series B in 2002
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.
Celarix
Private Equity Round in 2002
Celarix specializes in providing comprehensive web-based software solutions designed to streamline logistics operations. The company caters to both shippers and transportation service providers, offering tools that integrate various aspects of logistics management, including transactions, connectivity, and data quality. By connecting customers, internal systems, and supply chain partners through advanced messaging technologies, Celarix aims to enhance efficiency and reduce the complexity typically associated with managing disparate information in logistics operations.
Sabeus Photonics
Series C in 2001
Sabeus Photonics optical devices and expand manufacturing facilities. Sabeus supplies optical communications components.
Coriolis Networks
Series C in 2001
Coriolis Networks, headquartered in Boxborough, Mass., began in mid 1999 with a mission to develop a comprehensive approach to the needs of carriers for reliable and scalable optical network solutions. From the beginning, Coriolis Networks realized that success in this market would be based on providing customers with a solution that was compatible with existing SONET network architectures but dramatically improved on the data service delivery capability with new lower price points. Coriolis' target market is the network service provider community on a global basis. Our target customers include competitive and incumbent local exchange carriers, Internet service providers, and wholesale carriers that are building out their fiber-optic facilities to meet their end-user demands for more high-speed data services as well as traditional metro services.
Circadiant Systems
Series B in 2001
Circadiant Systems, Inc. specializes in manufacturing optical test systems designed for optical component developers, network equipment manufacturers, and telecom service providers. The company provides a range of products, including an electrical/optical compliance system for module, host card, and integrated circuit testing applications. Notable offerings include the HYDRA LRM-M and HYDRA MTS, which address challenges related to calibration, instrument drift, and system-to-system correlation that can impede product release and design cycles. Additionally, Circadiant Systems offers the optical standard tester-ST, which generates various optical impairments and automates performance testing of 10 Gb/s devices. Their product line also features tools for creating optical impairments, stressed receiver sensitivity conformance testing, and solutions for long reach multimode applications, as well as protocol layer and electronic dispersion compensation testing.
eRealty.com
Series B in 2001
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.
Provides services to measure Internet performance.
B-there.com
Venture Round in 2001
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.
Planalytics (B2B)
Venture Round in 2001
Planalytics, Inc. specializes in business weather intelligence, offering companies insights to understand and manage the impact of weather on their operations. Founded in 1996 and based in Berwyn, Pennsylvania, Planalytics provides analytics, online tools, reports, and consulting services that help organizations quantify weather's influence on demand and operational performance. The company utilizes advanced statistical methods, artificial intelligence, and machine learning to deliver actionable insights, enabling clients to integrate weather considerations into their business practices effectively. With a global presence that includes Europe, Mexico, and Latin America, Planalytics has evolved from a data provider to a comprehensive software-as-a-service platform, enhancing its capabilities to serve a diverse range of industries.
Matrix.Net
Series A in 2001
Incorporated in 1990, MIDS is a pioneer of electronic commerce. MIDS started Matrix IQ the first for-pay non-academic periodical distributed over the Internet drew the first maps of the Internet as a whole, conducted the first demographic survey of the Internet, MIDS Internet Average and first monitored the Internet as a whole. MIDS is known as the granddaddy of Internet monitoring service providers. Since 1993 MIDS has been collecting a continuous stream of data in Their Internet Weather Report MIDS Internet Weather Report. Since 1995, MIDS has been displaying IWR data on the web as animated GIF and Java maps of current conditions in the Internet. MIDS makes geographical maps of Internet hosts, hosts per capita, latencies, links, and other aspects of the Internet available.
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.
IPnetwork
Series B in 2000
IPnetwork is a business specialising in international advertising services. It facilitates the delivery of promotional content across diverse platforms such as television, radio, and internet-based channels. The company's core offering revolves around providing comprehensive solutions for clients seeking global exposure through these mediums.
Ascentive
Venture Round in 2000
Ascentive is a software development company that specializes in creating user-friendly applications to address everyday PC issues for both consumers and businesses. The company offers a range of products aimed at optimizing, cleaning, and accelerating personal computers, thereby enhancing their performance. With a diverse team of software developers, designers, marketers, and customer service professionals, Ascentive is committed to delivering innovative solutions backed by excellent customer support. The company has established itself as a market leader in the software industry, receiving recognition from various media outlets including The Wall Street Journal and Forbes. Its products are utilized by hundreds of thousands of customers across 55 countries, reflecting its global reach and impact.
Isochron Data
Series A in 2000
Isochron Data Corporation (Isochron) is the leading application service provider of enterprise information solutions and wireless devices for customers seeking to communicate with their distributed field assets. Isochron's solutions connect people, devices, and enterprise systems to provide customers with vital information to improve their top and bottom lines. With Isochron's solutions, managers have direct control over their field assets and immediate access to timely, accurate, and actionable information to better manage their businesses.
Factory Logic
Series A in 2000
Factory Logic, Inc. is a provider of factory management solutions based in Austin, Texas. Founded in 1993, the company specializes in developing the Streamline Lean Factory Management System, which offers operational management software designed to equip factory personnel with integrated tools necessary for designing, operating, and enhancing lean manufacturing facilities. The Lean Operations suite facilitates an integrated approach that aligns production with customer demand while ensuring stability within factory and supply chain operations. Additionally, Factory Logic engages in consulting projects, offering its expertise to various sectors, including automotive, electronics, industrial equipment, and aerospace. The company was previously known as Scintellect Systems, Inc. and has been operating as a subsidiary of SAP AG since December 2006.
Ineto operates as a new customer communications service provider.
Highway To Health
Venture Round in 2000
Highway to Health, (HTH) applies its dynamic Internet expertise to bring innovative online healthcare services and insurance to international travel, study, and commerce. Each year thousands of leisure and business travelers as well as international students and scholars protect themselves, their families, and their travel plans with HTH. Their programs combine comprehensive, competitively priced insurance products with critical travel health information, known as CityHealthProfiles, and online medical assistance services available through HTH TravelersClub. Members enjoy access to their community of pre-selected, contracted physicians in over 100 countries, and their interactive translation guides for brand-name pharmaceuticals and common medical terms and phrases.
Powered is a social marketing consultancy focused on assisting companies in enhancing their engagement within the digital and social landscape. The firm employs a comprehensive approach to social marketing, offering services that include strategy development, program planning and execution, content marketing, and blogger outreach. Additionally, Powered specializes in influencer activation, advocacy programs, and the creation of branded communities and events. By leveraging effective practices and technologies, Powered enables brands and publishers to connect with customers and build meaningful relationships through online communities.
WebVision
Series C in 2000
Webvisions provided shared hosting, dedicated server and co-location services to small and midsized businesses throughout Asia.
Go-Active
Venture Round in 2000
Go-Active is a new online application service provider for the health club industry
Utility Associates
Series B in 2000
Utility Associates, Inc. is a company that specializes in providing advanced software solutions and hardware for law enforcement, transportation agencies, and utility services. Founded in 2000 and based in Decatur, Georgia, the company offers a range of products, including body-worn and in-car cameras, mobile routers, and multimedia evidence management systems. Notable products include the Rocket IoT platform, which automates evidence gathering and enhances situational awareness, and AVaiL, a command and control application that delivers real-time tracking of mobile operations. Additionally, Utility Associates provides tools such as Smart Holster, which activates cameras automatically when a firearm is drawn, and Smart Patrolling for license plate recognition. The company also supports mobile resource management with solutions that integrate various data systems to optimize field operations, ensuring effective communication and connectivity for personnel and equipment in real-time.
BroadCloud Communications
Series A in 2000
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.
ibooks.com
Series B in 2000
ibooks.com is a mobile-based application that enables its users to download and read books on their iPhone, iPod touch, or iPad.
B-there.com
Venture Round in 2000
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.
Participate Systems
Series B in 2000
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.